Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Capital Expenditures (2022 - 2025)

Neuraxis (NRXS) has disclosed Capital Expenditures for 4 consecutive years, with $5862.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures changed N/A to $5862.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31150.0 through Dec 2025, up 12.15% year-over-year, with the annual reading at $31150.0 for FY2025, 12.15% up from the prior year.
  • Capital Expenditures hit $5862.0 in Q4 2025 for Neuraxis, down from $7288.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $18000.0 in Q1 2025 to a low of -$10000.0 in Q4 2022.
  • Historically, Capital Expenditures has averaged $7246.1 across 4 years, with a median of $7288.0 in 2025.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 260.4% in 2023 and later dropped 16.09% in 2025.
  • Year by year, Capital Expenditures stood at -$10000.0 in 2022, then surged by 260.4% to $16040.0 in 2023, then tumbled by 72.77% to $4368.0 in 2024, then skyrocketed by 34.2% to $5862.0 in 2025.
  • Business Quant data shows Capital Expenditures for NRXS at $5862.0 in Q4 2025, $7288.0 in Q2 2025, and $18000.0 in Q1 2025.